Skip to main content
SpringerLink
Log in

Survey of treatment recommendations for elderly patients with glioblastoma

  • Research Article
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Introduction

Glioblastoma, which is the most commonly diagnosed primary CNS neoplasm, is more frequent in individuals aged 65 years or more. Our purpose is to identify how glioblastoma diagnosed in elderly population is treated by Spanish oncologists.

Material and Methods

A survey was emailed to all members of Spanish Group for Neuro-oncology Research (GEINO).

Results

Twenty-six neuro-oncologists from 26 hospitals completed the survey. The answers were different depending on the age, performance status, and MGMT methylation status. Patients between 65 and 70 years of age are mainly treated with Stupp treatment. For patients between ages of 70 and 80 years, 46.2% made recommendations for Perry regimen, for both methylated and non-methylated patients. For patients older than 80  years, monotherapy treatment is considered more frequently. In cases of non-MGMT promoter methylation, systemic therapy with temozolomide is still recommended in many hospitals.

Conclusion

Our research demonstrates there is no uniform approach to the management of elderly patients with glioblastoma among academic neuro-oncologists.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hess KR, Broglio KR, Bondy ML. Adult glioma incidence trends in the United States, 1977–2000. Cancer. 2004;101:2293–9.

    Article  Google Scholar 

  2. Vuorinen V, Hinkka S, Färkkilä M, Jääskeläinen J. Debulking or biopsy of malignant glioma in elderly people - a randomised study. Acta Neurochir (Wien). 2003;145:5–10.

    Article  CAS  Google Scholar 

  3. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–96.

    Article  CAS  Google Scholar 

  4. Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008–2012. Neuro Oncol. 2015;17(suppl 4):iv1–iv62.

    Article  Google Scholar 

  5. Keime-Guibert F, Chinot O, Taillandier L, Cartalat-Carel S, Frenay M, Kantor G, et al. Radiotherapy for glioblastoma in the elderly. N Engl J Med. 2007;356:1527–35.

    Article  CAS  Google Scholar 

  6. Vourinen V, Hinkka S, Färkkilä M, Jääskeläinen J. Debulking or biopsy of malignant glioma in elderly people-a randomized study. Acta Nuerochir (Wien). 2003;145(1):1–5.

    Article  Google Scholar 

  7. Roa W, Brasher PM, Bauman G, Anthes M, Bruera E, Chan A, et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol. 2004;22:1583–8.

    Article  CAS  Google Scholar 

  8. Malmström A, Grønberg BH, Marosi C, Stupp R, Frappaz D, Schultz H, et al. Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol. 2012;13:916–26.

    Article  Google Scholar 

  9. Wick W, Platten M, Meisner C, Felsberg J, Tabatabai G, Simon M, Nikkhah G, Papsdorf K, et al. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytom in elderly people: the NOA-08 randomised, phase 3 trail. Lancet Oncol. 2012;13(7):707–15.

    Article  CAS  Google Scholar 

  10. Malmstrom A, Gronberg BH, Stupp R, et al. Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol. 2012;13(9):916–26.

    Article  Google Scholar 

  11. Minniti G, De Sanctis V, Muni R, Filippone F, Bozzao A, Valeriani M, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients. J Neurooncol. 2008;88:97–103.

    Article  CAS  Google Scholar 

  12. Minniti G, Lanzetta G, Scaringi C, Caporello P, Salvati M, Arcella A, et al. Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma. Int J Radiat Oncol Biol Phys. 2012;83:93–9.

    Article  CAS  Google Scholar 

  13. Brandes AA, Franceschi F, Tosoni A, et al. Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT methylation status. Cancer. 2009;115(15):3512–8.

    Article  CAS  Google Scholar 

  14. Perry JR, Laperriere N, O'Callaghan CJ, et al. Short-course radiation plus temozolomide in elderly patients with glioblastoma. N Engl J Med. 2017;376(11):1027.

    Article  CAS  Google Scholar 

  15. Lombardi G, Bergo E, Bellu L, Caccese M, Letterio A, Tierno G, Pambuku A, Brunello A, Zagonel V. Comprehensive Geriatric Assessment (CGA) for outcome prediction in elderly patients (PTS) with glioblastoma (GBM): a mono-institutional experience. ESMO. 2018;29:mdy273–mdy369.

    Google Scholar 

  16. Clone M, D’Amico R, Lebovic J, Nazarian M, Zacharia BE, Sisti MB, et al. Frailty in Geriatric Glioblastoma Patients: a predictor of operative morbidity and outcome. World Neurosurg. 2016;89:362–7.

    Article  Google Scholar 

  17. Hegi ME, Diserens A-C, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N engl J Med. 2005;352(10):997–1003.

    Article  CAS  Google Scholar 

  18. Wick W, Engel C, Combs SE, et al. NOA-08 randomized phase III trial of 1-week-on/1-week-off temozolomide versus involved field radiotherapy in elderly (older tan age 65) patients with newly diagnosed glioblastoma. J Clin Oncol. 2010;28:LBA2001.

    Article  Google Scholar 

  19. Malmstrom A, Gronberg BH, Stupp R, et al. Glioblastoma in elderly patients: a randomized phase III trial comparing survival in patients treats with 6-week radiotherapy versus hypofractionated RT over 2 week versus temozolomide single agent. J Clin Oncol. 2010;28:LBA2002.

    Article  Google Scholar 

  20. Van den Bent MJ, Baumert B, Erridge SC, et al. Interim results from the CATNON trial (EORTC study 26053–22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study. Lancet. 2017;390:1645.

    Article  Google Scholar 

  21. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, editors. WHO classification of tumours of the central nervous system. 4th ed. Lyon: IARC; 2016.

    Google Scholar 

Download references

Acknowledgements

We thank the collaboration of the oncologists who have sent the surveys: M. A. Vaz Salgado, A. Rodriguez Sánchez, T. Quintanar, M. Navarro Martin, M. Vieito Villar, J. Cano, S. González, S. Ros, A. Herrero, M. A. Ivars, M. Lloret, M. Alonso, I. Moya, R. Luque, M. Benavides, M. Gutiérrez Toribio, and J. García-Gómez.

Funding

None.

Author information

Authors and Affiliations

  1. Medical Oncology Department, Ramón y Cajal Hospital, Carretera de Colmenar Viejo Km 9.1, 28034, Madrid, Spain

    M. A. Vaz Salgado, J. Torres, J. Esteban & A. Carrato

  2. Neurosurgery Department, Ramón y Cajal Hospital, Carretera de Colmenar Viejo Km 9.1, 28034, Madrid, Spain

    J. A. Gutiérrez & L. Ley

Authors
  1. M. A. Vaz Salgado
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Torres
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Esteban
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. A. Gutiérrez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L. Ley
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Carrato
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. A. Vaz Salgado.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Research involving human participants and/or animals

The authors did not conduct research involving human participants or animals.

Informed consent

We did not use informed consent.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vaz Salgado, M.A., Torres, J., Esteban, J. et al. Survey of treatment recommendations for elderly patients with glioblastoma. Clin Transl Oncol 22, 1329–1334 (2020). https://doi.org/10.1007/s12094-019-02260-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-019-02260-2

Keywords

Search

Navigation